Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DHQD71
|
|||
Drug Name |
TAK-105
|
|||
Indication | Nausea and vomiting [ICD-11: MD90; ICD-10: R11] | Phase 1 | [1] | |
Company |
Takeda
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04964258) A Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-105 in Healthy Subjects. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.